Eric P Winer

发表

Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.

Nikhil Wagle, Gad Getz, J Christopher Love, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study.

Weili Lin, Donglin Zeng, Elizabeth Bullitt, 2007, Radiology.

Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update.

Sarat Chandarlapaty, Naren Ramakrishna, E. Winer, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).

Larry Norton, Donald A Berry, Edith A Perez, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.

Krishna R. Kalari, Jeanette E Eckel-Passow, Krishna R Kalari, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

James N Ingle, E. Winer, T. Powles, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.

Robert B Livingston, Gordan Srkalovic, Brian Leyland-Jones, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cardiac toxicity from systemic cancer therapy: a comprehensive review.

Giuseppe Curigliano, E. Winer, A. Goldhirsch, 2010, Progress in cardiovascular diseases.

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.

Robert B Livingston, Lois Shepherd, James N Ingle, 2010, The Lancet. Oncology.

Breast cancer. Clinical practice guidelines in oncology.

Krystyna Kiel, Mohammad Jahanzeb, Ingrid A Mayer, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.

Anastasia Ivanova, Charles M Perou, Katherine A Hoadley, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.

Jerry Avorn, E. Winer, J. Avorn, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The American Society of Clinical Oncology's Blueprint for Transforming Clinical and Translational Cancer Research.

Neal J Meropol, E. Winer, M. Kris, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pre-counseling education materials for BRCA testing: does tailoring make a difference?

Celette Sugg Skinner, Barbara K Rimer, Brian Calingaert, 2002, Genetic testing.

HER2 and response to paclitaxel in node-positive breast cancer.

Larry Norton, James N Ingle, Matthew J Ellis, 2007, The New England journal of medicine.

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

Donald Berry, Lyndsay N Harris, Lynn Dressler, 2006, Breast Cancer Research.

Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.

Barbara L. Smith, Robert Livingston, Richard L Schilsky, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.

E. Winer, G. Hortobagyi, Baljit Singh, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival.

Rulla M Tamimi, Yu-Ning Wong, Joyce C Niland, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.

John Kidd, Judy E Garber, E. Winer, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer

David Tuck, Vinay Varadan, Hannah Gilmore, 2016, Clinical Cancer Research.

The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care

Yulei He, Nancy L Keating, E. Winer, 2011, Cancer.

CNS metastases in breast cancer.

E. Winer, J. Bellon, N. Lin, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Local therapy and survival in breast cancer.

Monica Morrow, E. Winer, Jay R. Harris, 2007, The New England journal of medicine.

VEGF as a Marker for Outcome Among Advanced Breast Cancer Patients Receiving anti-VEGF Therapy with Bevacizumab and Vinorelbine Chemotherapy

Jerry Younger, Lyndsay N Harris, Judy E Garber, 2008, Clinical Cancer Research.

Web-based survey of fertility issues in young women with breast cancer.

E. Winer, J. Peppercorn, S. Gelber, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.

Jong-Hyeon Jeong, Norman Wolmark, Priya Rastogi, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.

Vered Stearns, J. Griggs, E. Winer, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.